Transparency data

COVID-19 self-test LFD post market surveillance

Periodic summary reports submitted to the MHRA as a post market surveillance condition of exceptional use authorisation DEU/012/2020/003

From:
UK Health Security Agency
Published
26 September 2024

Documents

Periodic summary reports submitted to the MHRA as a post market surveillance condition of exceptional use authorisation DEU/012/2020/003

HTML

Details

The attachment lists 30 periodic summary reports (PSRs) which were submitted to the Medicines and Healthcare products Regulatory Agency (MHRA) as a post market surveillance condition of the exceptional use authorisation DEU/012/2020/003.

Updates to this page

Published 26 September 2024

Sign up for emails or print this page